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Abstract: Directed evolution of oxidoreductases to improve their catalytic properties is being ardently 
pursued in the industrial, biotechnological, and biopharma sectors. Hampering this pursuit are current enzyme 
screening methods that are limited in terms of throughput, cost, time and complexity. We present a directed 
evolution strategy that allows for large-scale one-pot screening of glucose oxidase (GOx) enzyme libraries in 
well-mixed homogeneous solution. We used GOx variants displayed on the outer cell wall of yeasts to initiate 
a cascade reaction with horseradish peroxidase (HRP), resulting in peroxidase-mediated phenol cross-coupling 
and encapsulation of individual cells in well-defined fluorescent alginate hydrogel shells within ~10 minutes 
in mixed cell suspensions. Following application of denaturing stress to whole-cell GOx libraries, only cells 
displaying GOx variants with enhanced stability or catalytic activity were able to carry out the hydrogel 
encapsulation reaction. Fluorescence activated cell sorting was then used to isolate the enhanced variants. We 
characterized three of the newly evolved Aspergillus niger GOx enzyme sequences and found up to ~5-fold 
higher specific activity, enhanced thermal stability, and differentiable glycosylation patterns. By coupling 
intracellular gene expression with the rapid formation of an extracellular hydrogel capsule, our system 
improves high-throughput screening for directed evolution of H2O2-producing enzymes many fold.  
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Introduction 
Reaction compartmentalization at the cellular length scale is of high interest for directed evolution 
(Fischlechner et al., 2014; Sjostrom et al., 2014; Tawfik and Griffiths, 1998). The goal in such experiments is 
to combine the generation of genetic diversity together with screening or selection for enhanced phenotypic 
traits. Such approaches have been widely used for improving the performance of affinity proteins such as 
antibodies, as well as catalytic enzymes (Arnold, 2018; Denard et al., 2015; Jeschek et al., 2016; Packer and 
Liu, 2015; Powell et al., 2001; Taylor et al., 2001). Typically, screening for improved enzymatic activity is 
achievable only at low-to-medium throughput (<104 variants) because each enzyme variant has to be assayed 
individually, which can be time consuming and costly. Typically, each clone is isolated and grown in a separate 
well of a multi-well plate or in a separate colony on an agar plate. Each individual wells or colony then serves 
as reaction compartment which restricts diffusion of the enzyme reaction products localizing them to the site 
of production. This spatial co-localization allows for the necessary genotype-phenotype linkage for directed 
evolution to proceed. However, the requirement of separating genetic clones into different reaction 
compartments severely restricts the throughput of enzyme screens. This ultimately limits the size of the genetic 
libraries that can be screened, slowing down the evolutionary process. To address this shortcoming, various 
methods for microscale reaction compartmentalization have been developed, including single and double 
emulsions (Griffiths and Tawfik, 2006), and multi-phase microfluidic systems for droplet generation (Colin et 
al., 2015; Kintses et al., 2012). Multi-phase systems, however, may be cumbersome to implement, often 
requiring microfabricated devices and precise flow rate control. Furthermore, many droplet systems rely on 
cell-free transcription/translation, which may not be capable of glycosylation and other post-translational 
modifications that can affect protein activity, or may lack folding chaperones. 
The cell surface has also been utilized as a quasi-compartment. In such systems, bacteria can be 
labelled with fluorescent molecules or hydrogels when a target reaction occurs inside the cell (Lülsdorf et al., 
2015), or when displayed enzymes covalently modify the cell surface. Such approaches have been used, for 
example, to evolve peptide ligases (Chen et al., 2011) and oxidoreductases using a tyramide-fluorescein assay 
(Lipovsek et al., 2007; Ostafe et al., 2014). Although covalent cell-surface modification with small molecules 
offers some improvements, such systems can suffer from cross-reactivity between positive and negative cells, 
increasing the false-positive rate. 
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Directed evolution of accelerated or stabilized GOx variants is of considerable interest for the food 
and textile industries, as well as for blood glucose detection (Wong et al., 2008), deoxygenation of buffers for 
single-molecule fluorescence applications (Aitken et al., 2008), and oxygen inhibitor removal for radical 
polymerization (Chapman et al., 2014). Recently we reported a new method for single-cell encapsulation in 
hydrogel capsules that relied on a glucose oxidase (GOx) and horseradish peroxidase (HRP) enzyme cascade 
to cross-link phenol moieties grafted onto alginate and chitosan macromonomers (Vanella et al., 2019). The 
system we reported was made possible by GOx initiator enzymes that were synthesized by the cells from 
single-copy plasmids carrying the GOx gene, and surface-displayed on the outer cell wall. A competing 
approach has also been reported to produce hydrogels using a GOx cascade with Fenton’s reagent, which can 
produce hydroxyl radicals for polymerization of vinylated compounds and fluorophores (Malinowska et al., 
2014; Malinowska et al., 2015; Malinowska and Nash, 2016; Pitzler et al., 2014). Here, we report the utilization 
of the GOx-mediated cell encapsulation system for directed evolution of GOx. We utilized the GOx/HRP cell 
encapsulation system for screening of residual GOx activity following denaturing stress applied to a library of 
mutant GOx enzymes. Our strategy utilizes enzymatic radical polymerization to form a well defined uniform 
hydrogel shell around cells presenting active variants of the target enzyme. The 3D conformal nature of the 
hydrogel shells and the short lifetimes of the radical cross-linking species are features that allowed for 
essentially zero cross-reactivity (i.e., no false positive labelling) under our optimized conditions. The resultant 
GOx variants were isolated in soluble form and characterized using biophysical assays to shed light on the 
mechanisms involved in thermal and catalytic enhancement.  
 
Materials and Methods 
Materials. All the chemicals used in this work were purchased from Sigma Aldrich if not otherwise specified. 
The primary and secondary antibodies were purchased from Thermo Fisher Scientific. Restriction enzymes 
were purchased from New England Biolabs. Sodium Alginate (Viscosity 1%: 100 - 200 mPa⋅s) was purchased 
from Duchefa Biochemie. 
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Amplification, cloning, and yeast display of WT GOx. The GOx wild type gene was amplified from the 
genome of Aspergillus niger strain 4247 (LGC Standards) using the primers F1 and R1 (Table 1), and cloned 
using BamHI and XhoI restriction sites into the yeast plasmid pYD1 for protein display (gift from Dane 
Wittrup, Addgene plasmid #73447) (Kieke et al., 1997). After sequence confirmation, the plasmid pYD1-GOx 
was transformed into Saccharomyces cerevisiae EBY100 following a typical lithium acetate transformation 
(Gietz and Woods, 2002) procedure, followed by selection of positive colonies on SD agar 2% (w/v) glucose 
plates lacking tryptophan (-Trp). Resulting colonies were cultivated in  -Trp liquid medium with 2% glucose 
for 24 hours at 30°C to an OD600 ~8 with continuous shaking at 200 rpm. Protein expression and display was 
then induced by transferring the culture at a starting OD600 ~0.4 to fresh liquid medium lacking tryptophan 
containing 0.2% (w/v) glucose and 1.8% (w/v)  galactose, and shaking for 24 hours at 30°C. 
  
Preparation of fluorescent alginate with phenols groups. Alginate macromonomers grafted with phenol 
moieties and aminofluorescein was prepared through carbodiimide activation chemistry as previously reported 
(Sakai and Kawakami, 2007; Vanella et al., 2019). Sodium alginate (avg. MW 70,000 Da) was dissolved in 50 
mM MES buffer pH 6 (10 mg/mL), followed by addition of tyramine hydrochloride, NHS, and EDC at 
concentrations of 7, 1.2, and 3.9 mg/mL, respectively. Finally, 0.25 mg/mL of 6-aminofluorescein was added 
and the reaction was allowed to proceed at room temperature for ~18 hours with stirring. The modified alginate 
was then precipitated dropwise into an 80% ethanol solution in water, followed washing with 80% ethanol. 
The final product was dissolved in water prior to lyophilization. Modification was confirmed through 1H-
NMR.  
 
Cell encapsulation in fluorescent alginate hydrogels. Yeast cells in induction media displaying GOx were 
washed with 50 mM sodium phosphate buffer pH 7.4 and resuspended at OD600 = 0.2 (~2106 cells/mL). 
Glucose (100 mM), HRP (4.5 µM) and modified alginate (0.125% (w/v)) were added. The reaction was gently 
mixed and incubated at room temperature for 10 min, followed by four fold dilution by 50 mM sodium 
phosphate buffer pH 7.4. Samples were then analyzed through fluorescence microscopy or flow cytometry.  
GOx mutant library construction by error prone PCR. A GOx mutant library with a medium mutation 
frequency (4.5-9 mutations/ kb) was prepared by  amplifying the region between nucleotides 4 and 513 of the 
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GOx wild type gene in pYD1 through error prone PCR (GeneMorph II, Agilent) using primers F2 and R2 
(Table 1). The backbone of the recipient vector was amplified through PCR using primers F3 and R3 (Table 
1). The error prone PCR product and the pYD1 linearized backbone were then co-transformed into EBY100 
an assembled as a complete plasmid in vivo via gap repair (Oldenburg et al., 1997). After culturing of the 
positive clones on selective medium agar plates, the colonies were collected and grown for 24 hours in liquid 
media prior to induction of GOx expression and display.  
 
FACS-based screening. Yeast cells were sorted using a MoFLo XDP cell sorter from Beckman Coulter 
equipped with 488 nm and 561 nm lasers, and with a 100 µm nozzle. Prior to  sorting, GOx mutant libraries 
were treated with 5M guanidinium chloride for 10 minutes, washed 3 times, and stained with Propidium Iodide 
(final concentration of 4 µg/mL), followed by washing. Next, the same PI-stained cells were used for the 
encapsulation reaction under the following conditions: ~2106 cells/mL suspended in 50 mM sodium 
phosphate buffer, pH 7.4. Glucose, HRP and modified alginate were used at final concentrations of 100 mM, 
4.5 µM, and 0.125% (w/v), respectively. All single-cell events showing positive signal for the encapsulation 
reaction (fluorescein fluorescent signal) and negative for the staining with Propidium Iodide were sorted in 
single-cell mode (Figure S1).  
After sorting, single cells were cultured in liquid glucose medium lacking tryptophan for two days at 
30°C and spotted on agar plates with 2% (w/v) galactose lacking tryptophan in order to induce the GOx protein 
expression and display. After 2 days incubation at 30°C the colonies were used for an ABTS top-agar assay in 
order to test for the expression of GOx. The assay was performed by mixing 2% (w/v) agar with an equal 
volume of ABTS reaction solution containing 666 mM Glucose, 14 mM ABTS and 150 µg HRP and by 
pouring the mixture directly onto the colonies. After a few minutes green halos were observed around the 
colonies expressing GOx. Furthermore, after culturing the cells in liquid SD glucose medium lacking 
tryptophan the plasmids were isolated using the Zymoprep™ Yeast Plasmid Miniprep II kit. The sequences of 
the GOx mutant genes were then obtained through Sanger sequencing.  
 
Soluble protein expression and purification. Yeast colonies carrying the pYD1 vector with wild type or 
mutant GOx genes were grown in  -Trp liquid medium with 2% (w/v) glucose for 24 hours at 30°C with 
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continuous shaking at 200 rpm. Protein expression and display was induced by transferring the cells at an 
initial OD600 of 0.4 to a -Trp liquid medium containing the 1.8% (w/v) of galactose and 0.2 % (w/v) of glucose, 
and growing the cultures at 30°C while shaking at 200 rpm. After 24h, the cells were pelleted down and washed 
with 20 mM Hepes buffer pH 8 before being resuspended at an OD600 equal to ~50 in the same buffer 
containing 0.1 mM of DTT. The DTT-reduction reactions were incubated for 2.5 hours at room temperature 
with gentle shaking in order to reduce the disulfide bonds between Aga2 and Aga1 proteins which are 
responsible for anchoring GOx on the yeast surface. Afterwards the cells were pelleted down and the 
supernatant was loaded on an HiTrap ion exchange column. Aga2-GOx WT and Aga2-GOx mutants (M1, M2, 
and M3) were eluted by applying a NaCl gradient from 0 to 1M. The eluted proteins were collected in 1 ml 
fractions and all samples were tested for GOx activity using an ABTS assay (see below). Eluted fractions 
containing functional GOx were isolated and concentrated through a 100 kDa cutoff Vivaspin ultrafiltration 
column. Different GOx variants were compared in there native, denatured and deglycosylated using SDS-
PAGE. In order to cleave N-linked mannose and compare the proteins in their deglycosylated form, each 
protein (1µg) was denatured and treated with 1000 units of EndoH (NEB) enzyme at 37°C for 1h. 
 
Enzyme kinetic studies. Kinetic analyses of each GOx variant in soluble form was performed using an ABTS 
assay with different concentrations of glucose from 0.4 to 50 mM. The other components of the reactions were 
4.74 nM of Aga2-GOx WT or mutant enzyme, 4.5 µM HRP, 2 mM ABTS in 100 mM Sodium Phosphate 
Buffer at pH 7.4. The concentration of HRP used in the kinetic reactions was ~ 1000 times higher than the 
GOx concentration and was experimentally confirmed not to limit the rate of the reaction. All kinetic studies 
were performed in triplicates by following the absorbance of the ABTS substrate at 405 nm following 
processing by the GOx/HRP cascade. Absorbance values were converted to rates of product formation (µM s-
1 H202 ) using a standard curve. Enzyme kinetic data were fitted to the Michaelis-Menten equation using the 
GraphPad Prism 5 software in order to determine the Km and kcat values for each enzyme variant. The molar 
concentration of Aga2-GOx WT and M1, M2, and M3 mutants was set to 4.74 nM for each reaction using the 
Lambert-Beer law and considering the extinction coefficient at 280 nm based on the amino acid sequence of 
the respective proteins. 
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Thermostability studies. The thermostability of soluble wild-type and mutant GOx enzymes was determined 
by incubating 50 ng of each enzyme in 50 mM sodium phosphate buffer (pH 7.4) at increasing temperatures 
from 50 to 62.5 for 10 minutes. The sample was then cooled and residual activity of GOx was measured using 
the ABTS assay as described above. For each reaction the initial rate was calculated in the linear range of the 
curve. For each enzyme variant, the rate of the reaction catalyzed by that sample incubated at 50°C was 
considered 100% of activity; in order to calculate the residual activity, the initial reaction rates at the various 
temperatures were normalized to the initial rate at 50°C for the same protein. Additionally, temperature-
dependent differential scanning fluorescence was performed using the Prometheus instrument (NanoTemper). 
Samples of 0.1 mg/mL wild-type or GOx enzyme were analyzed in microcapillaries in 50 mM sodium 
phosphate buffer, pH 7.4.     
 
Results and Discussion 
GOx is a 160 kDa highly glycosylated homodimeric complex that binds 2 FAD cofactor molecules 
within a globular folded structure. During its catalytic cycle, GOx utilizes molecular oxygen as an electron 
acceptor, oxidizing ß-D-glucose to D-gluconolactone and producing hydrogen peroxide as a byproduct 
(Swoboda and Massey, 1965) (Figure 1A). We developed the current system relying on GOx and HRP 
working in tandem as a bi-enzymatic initiation system for polymerization of phenolated fluorescent 
macromonomers (Sakai et al., 2012; Sakai et al., 2013; Shoda et al., 2016; Sigg et al., 2011; Uyama et al., 
1997; Vanella et al., 2019; Zavada et al., 2016). To produce the macromonomers, we modified sodium alginate 
(MW = 70,000 g/mol) with tyramine and aminofluorescein (Figure 1B)  (Liu et al., 2014; Sakai and Kawakami, 
2007) using carbodiimide activation chemistry.  1H-NMR confirmed the presence of aromatic phenol and 
fluorescein groups in the resulting polymer (Vanella et al., 2019). The approach for directed evolution of GOx 
is presented in Figure 1C. We PCR amplified the full length GOx gene sequence from the genome of 
Aspergillus niger and cloned it into the pYD1 yeast display vector in frame with the a-agglutinin protein 
Aga2p. The sequence was confirmed by Sanger sequencing and the plasmid was transformed into S. cerevisiae 
EBY100 (Boder and Wittrup, 1997). EBY100 contains a genomic copy of Aga1p under control of a strong 
galactose promoter (pGAL). The GOx gene was contained on an episomal pYD1 plasmid also under control 
of the pGAL promoter and located downstream and in frame with the Aga1p domain. EBY100 is advantageous 
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for GOx directed evolution because it supports glycosylation and can display large proteins (Gonzalez-Perez 
et al., 2012). Indeed, this strain was previously used for GOx directed evolution using a multi-phase system 
for reaction compartmentalization (Ostafe et al., 2014). By supplementing the growth media with galactose, 
we induced a chromosomal copy of Aga1p and a plasmid copy of Aga2p-GOx. Immunostaining using anti-
Xpress protein tag antibodies labeled with Alexa Fluor 555 was used to verify translocation and anchoring of 
Aga2p-GOx to Aga1p on the outer cell wall. Analytical flow cytometry indicated that ~60% of cells in the 
population were fluorescently labeled, consistent with successful display of GOx. A positive result using an 
HRP/amplex red assay confirmed the activity of displayed GOx (data not shown).  
To encapsulate individual yeast cells using the GOx/HRP enzyme cascade, cells displaying functional 
GOx homodimers (2106 yeast cells/mL) were suspended in 100 mM glucose, 4.5 µM HRP, and 0.125% 
(w/v) of phenolated alginate. Following 10 minutes of incubation in the encapsulation solution, ~60% of cells 
showed positive fluorescent signals in the green channel due to the presence of fluorescein (Figure 2A) in the 
capsules. Confocal fluorescence microscopy (Figure 2B) indicated uniform and continuous fluorescent 
hydrogel shells encapsulating individual cells, 15-25 µm in diameter (including the cell diameter). We found 
that in order for the hydrogel encapsulation reaction to remain localized at the cell surface, the cell 
concentration in the reaction medium must not be set too high. At cell concentrations > 1107 cells/mL, the 
entire solution was found to cross-link and form a gel. At a cell concentration range of 2.5106 – 1107 
cells/mL, small hydrogel aggregates encapsulating multiple cells were observed. Maintaining cell 
concentrations at or below 2106 cells/mL resulted in singly encapsulated cells with no cross reactivity even 
after extended incubation. In order to avoid aggregation of the encapsulated cells post-polymerization, the 
reaction mixture was rapidly diluted 4-fold following the reaction time, and the encapsulated cell mixture was 
regularly agitated with a pipette prior to analysis by FACS. Centrifugation of the encapsulated cells was 
avoided. 
In previous work (Vanella et al., 2019), we validated the hydrogel encapsulation reaction as a cell 
screening tool by screening cell mixtures of diluted GOx positive cells in a background of pYD1 empty 
plasmid-containing cells, and observing a direct correspondence of selected positive cell concentrations in 
FACS plots. Green fluorescent cells sorted in single-cell mode from a reference mixture containing 10% GOx 
positive cells were re-cultured without any noticeable effect of the gel capsules on cell growth rate, and all 
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were found to be positive for GOx when tested using ABTS top agar assay. These results indicated there was 
a very low to zero background labeling of cells during the screening procedure, eliminating false positive 
events from the sorted cell mixtures. 
We next implemented the hydrogel encapsulation system for the isolation of GOx variants with 
enhanced properties. We targeted mutagenesis to the N-terminus of GOx, which accounts for the dimer 
interface. We applied a random mutagenesis approach, generating a pool of GOx mutants through error prone 
PCR targeting the first 500 nucleotides of the gene. This mutagenized PCR product was then transformed 
directly into yeast together with the linearized pYD1 plasmid and assembled in vivo by gap repair. We 
estimated the size of the library by counting the number of colonies per area on a representative area of the 
agar plates and multiplying by the total area of all the plates, obtaining an approximate library size of one half 
million GOx variants (~ 0.5106). By sequencing the plasmids of 5 randomly selected clones from the yeast 
library, we calculated an average mutation frequency of 8 mutations per kb.  
In order to screen the library, we disrupted the structure of GOx homodimers using high concentrations 
of gaunidinium hydrochloride (GdnHCl). We found that short term exposure to 5M GdnHCl followed by 
washing in PBS buffer irreversibly denatured the parent GOx enzyme resulting in complete inhibition of the 
cellular encapsulation reaction. Treatment of the yeast cells with 5M GdnHCl additionally resulted in partial 
cell death, with ~25% of the cells surviving and propagating in growth media without requiring plasmid 
extraction or re-transformation. This screening strategy allowed us to exclude clones that performed as well as 
or worse than wild type GOx, while maintaining a significant number of living cells capable of being isolated 
and expanded in culture. In the absence of GdnHCl, we observed no adverse effects of the gel capsules on cell 
growth following encapsulation (Vanella et al., 2019). Encapsulated cells were able to easily break out of the 
gel capsules and propagate in growth media.  
The screening procedure involved incubation of the mutant GOx library with 5M GdnHCl for 10 
minutes, followed by washing and addition of hydrogel encapsulation reagents to the cell mixture in a one-pot 
reaction. This approach assayed for residual GOx activity following GdnHCl treatment, whereby the presence 
of the hydrogel shell was correlated with more active or more stable GOx variants displayed on the cell wall. 
All cells trapped in fluorescent alginate and not stained by propidium iodide (PI), a fluorescent dye used to 
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label the dead cells, were isolated through single cell sorting and recultured for subsequent protein expression 
and characterization (Figure S1).  
The ultrahigh throughput nature of the 10-min one-pot encapsulation method allowed the analysis of 
more than 5106 library members in a single sorting session of less than 1 hour, providing ~10-fold coverage 
of the mutant library of size 0.5106. Selected cells were re-cultured and tested individually to compare the 
stability and activity of the displayed GOx variants to the parent enzyme. Following screening, the residual 
activity of 27 mutants along with wild type GOx was first tested in the cell display format. Each isolated clone 
was induced for GOx expression and incubated at elevated temperature as follows. Each clone was exposed to 
10 minutes of thermal stress at 70 °C, followed by exposure to the hydrogel encapsulation reagents. The 
fraction of encapsulated cells was then analyzed using flow cytometry (data not shown). The three GOx 
mutants that performed best under thermal stress in the cell surface-based assay were then purified as soluble 
Aga2-GOx fusion proteins and further analyzed. The obtained parental Aga2-GOx and the three mutant Aga2-
GOx enzymes are denoted WT, and M1, M2, and M3, respectively. It was previously reported (Blazic et al., 
2013) that Aga2-GOx fusion proteins produced using surface display in S. cerevisiae exhibited a ~ 1.5-fold 
decrease in catalytic turnover rate as compared with GOx lacking the Aga2 fusion domain. This prior work 
confirmed, however, that both an enhanced mutant and wild type GOx were affected equally by fusion with 
Aga2, indicating that detection of an improved GOx variant as an Aga2-fusion reflects improvement in the 
properties of the enzyme and not an artifact of the Aga2 fusion domain.  
The three evolved mutants (M1, M2, M3) and WT enzyme were released from their respective cell 
surfaces using dithiothreitol (DTT) to reduce the disulfide bonds between Aga1p and Aga2p-GOx. Soluble 
Aga2-GOx was then purified from the reduced cell supernatants using ion exchange chromatography. The 
resulting proteins were tested for kinetic parameters using a cascade HRP/ABTS assay (Figure 3A). All three 
mutants exhibited improved activity (Figure 3B), with M1 having 4.9-fold greater catalytic efficiency. M3 
exhibited the highest kcat value, which was 3.96-fold higher than WT. The Km values for M1, M2, and M3 were 
furthermore slightly lower than WT but not hugely improved. This was consistent with the selection step which 
was performed at a saturating substrate concentration of 100 mM glucose.  
Sequence analysis (Figure 3B) showed that the improvements in enzyme activity were achieved as a 
result of a single point mutation in the case of M1 and M3, or as the result of 2 mutations close together in 
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primary sequence in the case of M2. Each mutant presented a mutation which replaced a Leucine with Proline 
in position 9 or 13. In addition, M2 contained an additional mutation that replaced the Alanine at position 16 
with Threonine. The identified mutations were all located within the first 22 amino acids of the GOx protein 
leader peptide sequence. This region of the protein is cleaved off when the enzyme is expressed natively in A. 
niger. To the best of our knowledge, prior work on directed evolution of GOx in heterologous systems excluded 
the leader sequence, therefore the mutations identified here are newly reported sequences (Holland et al., 2012; 
Ostafe et al., 2014; Prodanovic et al., 2011; Zhu et al., 2007).  
Thermostability of the evolved mutants was evaluated by measuring normalized initial substrate 
turnover rate following 10 minute heat shock (Figure 3C). All three enzymes showed improvement in 
thermostability, with the largest improvement occurring at 55 °C, where the WT enzyme exhibited 59% 
residual activity while M1, M2, and M3 remained 74, 73, and 72% active, respectively.  Thermostability of 
WT, M1, M2 and M3 was further analyzed using nano differential scanning fluorescence (nanoDSF) (Figure 
4). NanoDSF determines protein denaturation temperature by monitoring the normalized intrinsic fluorescence 
ratio (350 nm / 330 nm) excited at 280 nm as a function of temperature. The nanoDSF results showed two 
denaturation peaks occurring at 53°C and 61 °C. For mutants M1 and M3, the peak at 61°C was significantly 
more prominent than the one at 53 °C, indicating a larger fraction of the sample denatured at the higher 
temperature. For mutant M2, the peaks at 61 °C and 53 °C were equally prominent. For wild type by contrast, 
the peak at 53°C was the dominant peak. This result indicates that the mutants exhibit a thermally stabilized 
dimer conformation that outperforms WT. Combining this result with SDS-PAGE analysis (see below), we 
attributed the lower temperature denaturation peak at 53°C to denaturation of GOx monomers, and the higher 
temperature denaturation peak at 61°C to denaturation of GOx dimers.  
We hypothesized that changes in GOx glycosylation resulting from the selected mutations could be 
responsible for the enhanced activity and thermal stability. With the introduction of a threonine residue, the 
A16T mutation in M2 introduces a candidate residue for O-linked glycosylation. The other isolated mutations 
resulted in introduction of a proline in place of leucine at position 9 or 13 (Figure 3B) directly adjacent to a 
serine residue, which is also a potential O-linked glycosylation site (Kukuruzinska et al., 1987). We found that 
digestion of WT, M1, M2, and M3 glycoproteins using endoglycosidase-H to cleave N-linked high mannose 
chains resulted in differently sized bands for M1-M3 as compared with WT when analyzed using SDS-PAGE 
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(Figure 5), suggesting that O-linked glycosylation of the mutants conferred activity and stability enhancement. 
Since availability for glycosylation depends on structure, we can speculate that the L9P and L13P mutations 
resulted in disordering of the alpha helix linker region and improved accessibility of the adjacent serine 
residues for O-mannosyltransferases, resulting in stabilization of the dimerized form of GOx.   
 
Conclusion 
We presented a system where localized GOx-mediated hydrogel polymerization at the cell surface 
provided an artificial cell phenotype that was utilized for directed evolution of the enzymatic initiator. The 
technique allowed screening of GOx libraries using one-pot encapsulation reactions in homogeneous medium. 
The screening procedure consisted of only 10 minutes incubation of the mutant library followed by washing 
and flow cytometric sorting, without requiring additional reaction compartmentalization or robotic sampling. 
The potential throughput for screening enzymes is limited in this case only by the speed of flow cytometry 
(~107 cells/hour). This level of throughput significantly accelerates the enzyme screening step as  compared to 
competing methods. In addition to GOx, other classes of enzymes are compatible with similar reaction schemes 
to achieve cross-linking of synthetic hydrogels for directed evolution, including other oxidoreductases, 
peroxidases, and laccases. We validated our system by screening and successfully isolating several stable GOx 
mutants exhibiting up to 4.9-fold higher catalytic efficiency which was achieved through large improvements 
of kcat and comparatively smaller improvements in Km. We characterized the differences in thermal stability 
and glycosylation profiles of the mutant enzymes to account for their ability to outperform the wild type under 
the assay conditions. Previously, a mutant Aga2-GOx called B11 was purified and characterized (Blazic et al., 
2013) with kcat=80 s-1, KM=16 mM, and catalytic efficiency =5.0. Our Aga2-GOx mutant M1 reported here by 
comparison exhibits kcat=136.1 s-1, KM=10.68 mM, and catalytic efficiency =12.74. Meanwhile our Aga2-GOx 
mutant M3 exhibits kcat=197.2 s-1, KM=16.76 mM, and catalytic efficiency =11.76. We demonstrated that the 
cell encapsulation system works for WT-GOx and GOx mutants with catalytic turnover numbers (kcat) in a 
range of ~50-200 s-1. To adapt the system to enzymes with significantly lower turnover rates, further 
optimization would be necessary. Our approach of enzyme-mediated polymerization provides an important 
selection tool for the directed evolution campaigns of many industrially and medically relevant oxidoreductase 
enzymes.  
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Tables 
Name Sequence (5’-3’) 
F1 GCATACGGATCCATGCAGACTCTCCTTGTGAGCTCGC 
R1 GCATACCTCGAGCTGCATGGAAGCATAATCTTCC 
F2 TCGGGATCTGTACGACGATGACGATAAGGTACCAGGATCCATG 
R2 CAGGATGCGTTGAAGTAGTGGCCAGCAGCGATCTGTTTGGC 
F3 GCCAAACATATCGCTGCTGGCCACTACTTCAACGCATCCTG 
R3 CATGGATCCTGGTACCTTATCGTCATCGTCGTACAGATCC 
Table 1. List of DNA primers used in this work.  
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Figures
 
Figure 1. Overview of GOx directed evolution using enzymatic hydrogel polymerization. (A) Structural 
model of GOx homodimer from A. niger (PDB code 1cf3). The N-terminal residues subjected to genetic 
diversification are highlighted in orange. The constant region residues are shown in blue. The FAD cofactor is 
shown as a surface plot in green. (B) Chemical structure of modified alginate used for cell encapsulation. (C) 
Scheme depicting gene induction and yeast display of GOx homodimer, followed by enzyme-mediated cross-
linking of phenolated fluorescent alginate into a conformal hydrogel surrounding the cell.  
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Figure 2. Yeast cells encapsulated in fluorescent alginate. (A) Flow cytometry plot of a yeast cell population 
displaying GOx and coated with fluorescent hydrogel. (B) Scanning confocal fluorescence microscopy images 
of single yeast cells encapsulated in fluorescent alginate shells. 
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Figure 3. Kinetic parameters and thermal stability of WT and evolved mutant GOx. (A) Kinetic plots 
showing initial rates of product formation vs. substrate concentration for WT and mutant GOx. (B) Mutation 
sites and kinetic parameters for WT and mutant GOx. (C) Thermostability of WT and mutant GOx was 
compared using normalized initial activity following heat shock at a given temperature (n=3).  
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Figure 4. Thermal denaturation curves of GOx wild type (WT) and mutant enzymes (M1, M2, M3). 
Changes in the fluorescence emission ratio (350 nm / 330 nm) excited at 280 nm were detected using the 
Prometheus NT.48. Each experiment was run in triplicate at a protein concentration of 0.1 mg/ml. Curves show 
the average of 3 runs.  
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Figure 5. SDS-PAGE of purified Aga2-GOx wt, M1, M2, and M3 fusion proteins. Each sample (1µg)  was 
loaded respectively in non-denaturing form, after denaturation with 2-Mercaptoethanol and incubation at 95°C, 
or after denaturation and incubation for 1 hour with 1000 units of EndoH enzyme. The glycosylated samples 
appear as smears due to variations in glycosylation levels. Treatment with EndoH caused cleavage of 
chitobiose from high mannose and some hybrid N-linked oligosaccharides revealing a more defined pattern as 
compared with the wild type.  
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Protein sequences 
Amino acid changes relative to the wild type sequence of Glucose Oxidase are highlighted red. 
 
Aga2p_ GOx (wild type)               ε280 = 104,170 M-1 cm-1 
MQLLRCFSIFSVIASVLAQELTTICEQIPSPTLESTPYSLSTTTILANGKAMQGVFEYYK
SVTFVSNCGSHPSTTSKGSPINTQYVFKLLQASGGGGSGGGGSGGGGSASMTGGQQMGRDL
YDDDDKVPGSMQTLLVSSLVVSLAAALPHYIRSNGIEASLLTDPKDVSGRTVDYIIAGGGLTG
LTTAARLTENPNISVLVIESGSYESDRGPIIEDLNAYGDIFGSSVDHAYETVELATNNQTALIRS
GNGLGGSTLVNGGTWTRPHKAQVDSWETVFGNEGWNWDNVAAYSLQAERARAPNAKQIA
AGHYFNASCHGVNGTVHAGPRDTGDDYSPIVKALMSAVEDRGVPTKKDFGCGDPHGVSMF
PNTLHEDQVRSDAAREWLLPNYQRPNLQVLTGQYVGKVLLSQNGTTPRAVGVEFGTHKGN
THNVYAKHEVLLAAGSAVSPTILEYSGIGMKSILEPLGIDTVVDLPVGLNLQDQTTATVRSRIT
SAGAGQGQAAWFATFNETFGDYSEKAHELLNTKLEQWAEEAVARGGFHNTTALLIQYENY
RDWIVNHNVAYSELFLDTAGVASFDVWDLLPFTRGYVHILDKDPYLHHFAYDPQYFLNELD
LLGQAAATQLARNISNSGAMQTYFAGETIPGDNLAYDADLSAWTEYIPYHFRPNYHGVGTCS
MMPKEMGGVVDNAARVYGVQGLRVIDGSIPPTQMSSHVMTVFYAMALKISDAILEDYASM
Q LESRGPFEGKPIPNPLLGLDSTRTG HHHHHH* 
 
Aga2p_ GOx (Mutant 1)           ε280 = 104,170 M-1 cm-1 
MQLLRCFSIFSVIASVLAQELTTICEQIPSPTLESTPYSLSTTTILANGKAMQGVFEYYK
SVTFVSNCGSHPSTTSKGSPINTQYVFKLLQASGGGGSGGGGSGGGGSASMTGGQQMGRDL
YDDDDKVPGSMQTLLVSSPVVSLAAALPHYIRSNGIEASLLTDPKDVSGRTVDYIIAGGGLTG
LTTAARLTENPNISVLVIESGSYESDRGPIIEDLNAYGDIFGSSVDHAYETVELATNNQTALIRS
GNGLGGSTLVNGGTWTRPHKAQVDSWETVFGNEGWNWDNVAAYSLQAERARAPNAKQIA
AGHYFNASCHGVNGTVHAGPRDTGDDYSPIVKALMSAVEDRGVPTKKDFGCGDPHGVSMF
PNTLHEDQVRSDAAREWLLPNYQRPNLQVLTGQYVGKVLLSQNGTTPRAVGVEFGTHKGN
THNVYAKHEVLLAAGSAVSPTILEYSGIGMKSILEPLGIDTVVDLPVGLNLQDQTTATVRSRIT
SAGAGQGQAAWFATFNETFGDYSEKAHELLNTKLEQWAEEAVARGGFHNTTALLIQYENY
RDWIVNHNVAYSELFLDTAGVASFDVWDLLPFTRGYVHILDKDPYLHHFAYDPQYFLNELD
LLGQAAATQLARNISNSGAMQTYFAGETIPGDNLAYDADLSAWTEYIPYHFRPNYHGVGTCS
MMPKEMGGVVDNAARVYGVQGLRVIDGSIPPTQMSSHVMTVFYAMALKISDAILEDYASM
Q LESRGPFEGKPIPNPLLGLDSTRTG HHHHHH* 
 
 
  
 
2 
Aga2p_ GOx (Mutant 2)               ε280 = 104,170 M-1 cm-1 
MQLLRCFSIFSVIASVLAQELTTICEQIPSPTLESTPYSLSTTTILANGKAMQGVFEYYK
SVTFVSNCGSHPSTTSKGSPINTQYVFKLLQASGGGGSGGGGSGGGGSASMTGGQQMGRDL
YDDDDKVPGSMQTLLVSSLVVSPAATLPHYIRSNGIEASLLTDPKDVSGRTVDYIIAGGGLTG
LTTAARLTENPNISVLVIESGSYESDRGPIIEDLNAYGDIFGSSVDHAYETVELATNNQTALIRS
GNGLGGSTLVNGGTWTRPHKAQVDSWETVFGNEGWNWDNVAAYSLQAERARAPNAKQIA
AGHYFNASCHGVNGTVHAGPRDTGDDYSPIVKALMSAVEDRGVPTKKDFGCGDPHGVSMF
PNTLHEDQVRSDAAREWLLPNYQRPNLQVLTGQYVGKVLLSQNGTTPRAVGVEFGTHKGN
THNVYAKHEVLLAAGSAVSPTILEYSGIGMKSILEPLGIDTVVDLPVGLNLQDQTTATVRSRIT
SAGAGQGQAAWFATFNETFGDYSEKAHELLNTKLEQWAEEAVARGGFHNTTALLIQYENY
RDWIVNHNVAYSELFLDTAGVASFDVWDLLPFTRGYVHILDKDPYLHHFAYDPQYFLNELD
LLGQAAATQLARNISNSGAMQTYFAGETIPGDNLAYDADLSAWTEYIPYHFRPNYHGVGTCS
MMPKEMGGVVDNAARVYGVQGLRVIDGSIPPTQMSSHVMTVFYAMALKISDAILEDYASM
Q LESRGPFEGKPIPNPLLGLDSTRTG HHHHHH* 
 
Aga2p_ GOx (Mutant 3)                          ε280 = 104,170 M-1 cm-1 
MQLLRCFSIFSVIASVLAQELTTICEQIPSPTLESTPYSLSTTTILANGKAMQGVFEYYK
SVTFVSNCGSHPSTTSKGSPINTQYVFKLLQASGGGGSGGGGSGGGGSASMTGGQQMGRDL
YDDDDKVPGSMQTLLVSSLVVSPAAALPHYIRSNGIEASLLTDPKDVSGRTVDYIIAGGGLTG
LTTAARLTENPNISVLVIESGSYESDRGPIIEDLNAYGDIFGSSVDHAYETVELATNNQTALIRS
GNGLGGSTLVNGGTWTRPHKAQVDSWETVFGNEGWNWDNVAAYSLQAERARAPNAKQIA
AGHYFNASCHGVNGTVHAGPRDTGDDYSPIVKALMSAVEDRGVPTKKDFGCGDPHGVSMF
PNTLHEDQVRSDAAREWLLPNYQRPNLQVLTGQYVGKVLLSQNGTTPRAVGVEFGTHKGN
THNVYAKHEVLLAAGSAVSPTILEYSGIGMKSILEPLGIDTVVDLPVGLNLQDQTTATVRSRIT
SAGAGQGQAAWFATFNETFGDYSEKAHELLNTKLEQWAEEAVARGGFHNTTALLIQYENY
RDWIVNHNVAYSELFLDTAGVASFDVWDLLPFTRGYVHILDKDPYLHHFAYDPQYFLNELD
LLGQAAATQLARNISNSGAMQTYFAGETIPGDNLAYDADLSAWTEYIPYHFRPNYHGVGTCS
MMPKEMGGVVDNAARVYGVQGLRVIDGSIPPTQMSSHVMTVFYAMALKISDAILEDYASM
Q LESRGPFEGKPIPNPLLGLDSTRTG HHHHHH* 
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Figure S1. (A) Flow cytometric plot of the GOx mutant library encapsulated with green fluorescent 
alginate before and after treatment with guanidium chloride (GdnHCl). Gate R1 surrounds the cells 
displaying functional GOx that have been encapsulated with modified alginate. The plot “before 
GdnHCl” shows 10,000 events. The plot “after GdnHCl” shows 90,000 single events in order for the 
gated events to be easily visible. (B) Flow cytometry analysis of the yeast gene mutant library 
incubated with 5M Guanidinium Chloride and treated with Propidium Iodide (PI) before being 
assayed through cell encapsulation for residual activity of Glucose Oxidase. The cells gated in R4 
(positive for encapsulation in fluorescent alginate hydrogel and negative for PI) were sorted and re-
cultured for the isolation of the evolved enzymes.  
